SCHEMBL2355237

SCHEMBL2355237

C1CNCCNCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1003923 1.00 CXCR4 (0.75)
SCHEMBL8198989 1.00 CXCR4 (0.75)
SCHEMBL6883302 1.00 CXCR4 (0.75)
SCHEMBL8191860 1.00 CXCR4 (0.75)
SCHEMBL28179256 0.96 CXCR4 (0.69)
SCHEMBL27953016 0.96 CXCR4 (0.69)
SCHEMBL10540249 0.96 CXCR4 (0.69)
Ammonia Solution, Strong SCHEMBL28222091 0.96 CXCR4 (0.69)
SCHEMBL6272412 0.96 CXCR4 (0.67)
SCHEMBL3993518 0.96 CXCR4 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119343336-A 1, 4-Bis- (2-hydroxy-benzyl) -1,4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (III) complexes for use as MRI contrast agents 伯拉考成像股份公司 2025-01-21 CN claimed
WO-1990007261-A2 PROCESS FOR PREPARING MONO-N-ALKYLATED POLYAZAMACROCYCLES THE DOW CHEMICAL COMPANY (US) 1990-07-12 WO claimed
CN-119343336-A 1, 4-Bis- (2-hydroxy-benzyl) -1,4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (III) complexes for use as MRI contrast agents 伯拉考成像股份公司 2025-01-21 CN disclosed
CN-116617421-A Pharmaceutical composition for diagnosis and/or therapy 慕尼黑工业大学 2023-08-22 CN disclosed
EP-3318555-B1 BIFUNCTIONAL CHELATING AGENTS BWXT MEDICAL LTD (CA) 2023-08-16 EP disclosed
CN-111182927-B PSMA ligands for imaging and intracavity radiation therapy 慕尼黑工业大学 2023-07-21 CN disclosed
EP-3318555-A1 BIFUNCTIONAL CHELATING AGENTS Nordion (Canada) Inc. (CA) 2018-05-09 EP disclosed
EP-2536691-B1 BIFUNCTIONAL CHELATING AGENTS Nordion (Canada) Inc (CA) 2017-11-22 EP disclosed
US-8772446-B2 Bifunctional chelating agents NORDION (CANADA) INC. (CA) 2014-07-08 US disclosed
EP-2536691-A1 BIFUNCTIONAL CHELATING AGENTS Nordion (Canada) Inc. (CA) 2012-12-26 EP disclosed
US-20110313130-A1 BIFUNCTIONAL CHELATING AGENTS NORDION (CANADA) INC. 2011-12-22 US disclosed
WO-2011100829-A1 BIFUNCTIONAL CHELATING AGENTS NORDION (CANADA) INC. (CA) 2011-08-25 WO disclosed
CN-1250534-C Process for the manufacture of hydroxy ester derivative intermediates and epoxy resins prepared therefrom DOW GLOBAL TECHNOLOGIES COMPAN (US) 2006-04-12 CN disclosed
CN-1667014-A Process for manufacturing a hydroxyester derivative intermediate DOW CHEMICAL CO (US) 2005-09-14 CN disclosed
CN-1439027-A Process for the manufacture of hydroxy ester derivative intermediates and epoxy resins prepared therefrom DOW GLOBAL TECHNOLOGIES COMPAN (US) 2003-08-27 CN disclosed
EP-0374929-B1 Process for preparing mono-N-alkylated polyazamacrocycles DOW CHEMICAL CO (US) 1998-03-25 EP disclosed
US-5710292-A RHENIUM CATALYSTS HOECHST AKTIENGESELLSCHAFT (DE) 1998-01-20 US disclosed
US-5064956-A Process for preparing mono-n-alkylated polyazamacrocycles THE DOW CHEMICAL COMPANY (US) 1991-11-12 US disclosed
WO-1990007261-A2 PROCESS FOR PREPARING MONO-N-ALKYLATED POLYAZAMACROCYCLES THE DOW CHEMICAL COMPANY (US) 1990-07-12 WO disclosed
EP-0374929-A1 Process for preparing mono-n-alkylated polyazamacrocycles THE DOW CHEMICAL COMPANY (US) 1990-06-27 EP disclosed